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ABSTRACT
INTRODUCTION: Health-related quality of life (HR-QoL) is an essential index of outcome after acute 
ischemic stroke (AIS). The minimal clinically important differences (MCIDs) represent the smallest change 
detected by a specific HR-QoL measuring tool beyond the standard measurement error.
AIM: We aimed to establish the MCID in the HR-QoL after AIS during the first three months post-stroke.  
MATERIALS AND METHODS: A total of 143 participants were assessed using the Stroke Impact Scale 
3.0 (SIS 3.0) to measure HR-QoL at discharge, the first and the third month after AIS. Aggregated scores 
between 0-100 for all domains were used. MCID was defined as positive changes (PCs)(+15 points), negative 
changes (NCs)(–15 points), and no significant difference (NSDs)(–14 to +14). General linear modeling was 
used to determine time changes, and the differences were considered significant at a p-value <0.05. 
RESULTS: The most affected SIS 3.0 domains on the third month were Mobility - 56.74, Hand function - 
58.92, and Strength - 59.62. The majority of the patients had NSDs. The proportion of those with NCs was 
significantly lower than those of PCs. The domains with most PCs were Stroke recovery - 34.97%, Strength - 
33.57%, and Mobility - 31.47%, while Memory and thinking had the least - 13.29%. The most NCs were found 
in the domains Participation - 4.90%, Emotion - 4.20%, and Hand function -3.50%. The emotion domain 
manifested with the greatest variety ranging from 25.87% PCs and 4.20% NCs.
CONCLUSION: The most affected HR-QoL aspects were from the physical dimension, with an additionally 
high level of engagement of the emotional sphere. Stroke survivors require a holistic approach during the 
recovery period, including physical and speech rehabilitation and timely social and mental support.
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INTRODUCTION
Stroke is one of the leading causes of death and 
chronic disability worldwide (1). In the last decades, 
the global incidence of ischemic stroke has increased 
by 20% in the middle- and low-income countries 
(2). In Bulgaria, stroke is a constant leading cause of 
mortality and disability as the country ranks first in 
the EU in terms of the stroke mortality rates (3). 
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Ischemic stroke is a neurological disease with 
an immense impact on the stroke survivors’ lives. 
It causes lifetime disabilities with the consequences 
of functional difficulties and severe activity limita-
tions (4). Тhe assessment of recovery from an isch-
emic stroke should include different areas (domains) 
of their quality of life (QoL), which are affected by 
the disease. 
There is rising interest in the health-related 
quality of life (HR-QoL) after acute ischemic stroke 
(5). The information collected from the stroke sur-
vivors’ perspective on the consequences of stroke is 
critical for evaluating the recovery process. Many 
disease-specific tools are developed to provide infor-
mation about the difficulties patients who survived 
an acute ischemic stroke may experience (6).
Despite the need to determine the overall level 
of QoL, other properties such as the minimal clini-
cally important difference (MCID) are also of great 
importance. MCID is the smallest change detect-
ed by a certain HR-QoL measuring tool beyond the 
standard measurement error (7). This parameter fa-
cilitates the interpretation of treatment outcomes and 
allows individual groups’ delimitation with minimal 
positive or negative change over time.
There is a lack of information about the conse-
quences of acute ischemic stroke in Bulgaria. This is 
the first study to establish HR-QoL after acute isch-
emic stroke and determine MCIDs during the first 
three months post-stroke. 
MATERIALS AND METHODS
Study Design and Participants
We conducted a prospective, hospital-based 
study undertaken from July 2019 to June 2020 in the 
Second Clinic of Neurology with ICU and Stroke Unit 
at the “St. Marina” University Hospital, Varna. This 
center is the largest one providing differentiated treat-
ment of acute stroke patients, including thrombolysis 
and mechanical thrombectomy, in Eastern Bulgaria. 
Consecutive patients with first-ever and recur-
rent acute ischemic stroke (AIS) hospitalized in our 
clinic were included in the present study. At base-
line we recruited a total of 150 participants –  50 
patients with thrombolytic therapy and 100 – with 
non-thrombolytic treatment. We used the Ameri-
can Heart Association/American Stroke Association 
(AHA/ASA) definition of stroke (8). Ethical permis-
sion was obtained from the ethics committee of the 
Medical University of Varna. All participants pro-
vided signed informed consent.
We accepted the following inclusion criteria: 
age of 18 years or more; acute onset of neurologi-
cal symptoms lasting more than 24 hours; conduct-
ed neuroimaging examination of the head – comput-
ed tomography (CT) or magnetic resonance imaging 
(MRI); and signed informed consent. 
Exclusion criteria were: age under 18 years; lack 
of neurological symptoms or the presence of such 
was less than 24 hours; refusal to sign an informed 
consent. 
Patients with a transient ischemic attack (TIA) 
were not included in the present study. 
Clinical Evaluation and Measures
A neurologist similarly interviewed all partic-
ipants to get accurate sociodemographic data, in-
formation for comorbidities, and stroke risk factors. 
Medical records were checked, and relatives and care-
givers were also interviewed. All participants under-
went a detailed medical examination with thorough 
neurological status, blood tests, and neuroimaging – 
CT on admission. 
Stroke severity was measured on admission and 
at discharge from the clinic using the National Insti-
tutes of Health Stroke Scale (NIHSS) (9). Disability 
and functional independence of patients were mea-
sured using the modified Rankin Scale (mRS) (10). 
Stroke survivors were categorized as functionally in-
dependent (mRS 0-2 points) and functionally depen-
dent (mRS 3-5 points) in their daily activities.
The Stroke Impact Scale version 3.0 (SIS 3.0) (11) 
was applied to evaluate HR-QoL on discharge and 
at two follow-ups – at the first and the third month 
post-stroke. SIS 3.0 is a comprehensive specific mea-
sure for QoL in post-stroke patients. This scale has 
been proven suitable for a post-stroke patient follow-
up, as it has high reliability, sensitivity, and reproduc-
ibility for each domain (6). It consists of 59 items in 
8 domains – Strength, Hand function, Activities of 
daily living (ADL), Mobility, Communication, Emo-
tion, Memory and thinking, and Participation (12). 
The first four of the domains are combined in a com-
posite physical domain score. Each item is being rat-
ed on a five-point Likert scale, where 1 stands for in-
ability to complete the item, and 5 is equal to no dif-
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ficulties at all. There is a total score for each domain 
and an overall score for the whole questionnaire. Pa-
tients self-report the recovery from stroke using a vi-
sual analogue scale (VAS) ranging from 0 – no recov-
ery, to 100 denoting a full recovery. In this study, we 
used the domain-specific and total SIS 3.0 score for 
the measure of HR-QoL.
There is no defined range of the change to de-
termine MCID for SIS 3.0. Nevertheless, numerous 
studies have characterized the MCID range as 10% of 
the total range of scales. Other researchers set MCID 
in the range between 10% and 15% based on clini-
cal experience (4). Our study accepted MCIDs as a 
change of 15% of the total range scale. Subsequently, 
we defined positive changes (PCs) (+15 points), neg-
ative changes (NCs) (–15 points), and no significant 
differences (NSDs) (between –14 to +14).
Statistical Analysis
The data analysis was carried out using gold 
standard methods widely reported in the HR-QoL 
literature (12). We analyzed the HR-QoL data ob-
tained at all three time points. The items were re-
calibrated so that a high score always indicates bet-
ter HR-QoL. The domain results were later rescaled 
by the following equation - Domain score = [(Mean 
item score – 1) / 5-1] x 100. The calculated final scores 
have a standard range from 0 to 100, where a score of 
100 denotes the best health (4). The overall HR-QoL 
score was generated by finding the arithmetic mean 
of all the domain scores.
The statistical analysis included descriptive and 
inferential statistics. A comparison of the partici-
pants’ responses was made using ANOVA and cor-
relation statistics. General linear modeling was used 
to measure the changes in all SIS 3.0 domains over 
time. Wherever possible, confidence intervals (CIs) 
were calculated. Statistical significance was defined 
as a p-value (alpha) of 0.05 or less.
Data were analyzed using the software pro-
grams SPSS, version 23.00 (IBM Statistics, USA) and 
GraphPad Prism, version 5.00 (GraphPad Software, 
San Diego California, USA).
RESULTS
Baseline Characteristics
At baseline, there were 150 participants. Dur-
ing the three-month follow-up period, in 7 of the pa-
tients were registered fatal outcomes, representing a 
lethal rate of 4.67%. The final sample comprised 143 
participants.
The mean age of the ischemic stroke survivors 
was 68.54±11.44 years, comprising 88 males and 55 
females. One-third of the participants we treated with 
thrombolysis. Predominantly the patients were with 
a first-ever stroke – 111 cases, and less than a quar-
ter were with a recurrent stroke – 32 of them. Most of 
the patients had a moderate and minor stroke, as the 
mean NIHSS score on admission was 7.67±4.51 and 
4.59±3.59 on discharge. The mean mRS score at dis-
charge was 2.52±1.41 as 44.8% of the patients were 






Age Mean (years) 68.54 ± 11.44
>65 years 90 62.9
Sex Male 88 61.5Female 55 38.5
Ischemic stroke
First-ever stroke 111 77.6
Recurrent stroke 32 22.4
Localization
Anterior circulation 73 51.1
Left hemisphere 44 30.8
Right hemisphere 29 20.3
Posterior circulation 72 48.9
Stroke severity 
on admission Mean (NIHSS) 7.67±4.51
Minor stroke (1-4) 39 27.3
Moderate stroke 
(5-15) 90 62.9
Moderate to severe 
stroke (16-20) 14 9.8
Stroke severity 













Table 1. Patient characteristics at baseline
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tailed baseline characteristics of the participants are 
presented in Table 1.
HR-QoL After Ischemic Stroke
All participants reported a significantly re-
duced HR-QoL at discharge as the mean total QoL 
was 65.33±23.78. The lowest results were found in the 
following domains: Mobility - 56.74, Hand function 
-  58.92, and Strength - 59.62. The mean self-assessed 
stroke recovery was 45.27, which indicated the severe 
post-stroke consequences for the survivors.
During the time between discharge and the first 
month (Period I), all the domains of SIS 3.0 showed 
changes, however, the only statistically significant 
change was in the stroke recovery domain (p=0.028).
In the second period the trend of improvement 
in all domains continued, but to a lesser extent. The 
general linear modeling showed an advance in all 
studied fields by the SIS 3.0, without reaching a sta-
tistical significance. The Emotion domain presented 
with the most remarkable change but yet without a 
significant rate (p=0.127).
The most significant HR-QoL changes were 
noted between the discharge and the third month af-
ter AIS. Improvement in all aspects of life studied by 
the SIS 3.0 was observed. The most notable improve-
ment was found in the Emotion domain and the self-
reported stroke recovery (p<0.001). Consequent-
ly, Mobility (p=0.004) and Strength (p=0.007) were 
the domains with the most considerable improve-
ment. Finally, the total physical dimension (p=0.049) 
and the total QoL (p=0.019) presented significant 
improvement. 
Detailed information regarding the dynamics of 
HR-QoL in the three periods are presented in Table 2.
Minimal Clinically Important Differences 
(MCIDs)
The MCIDs analysis shows some main trends 
within the three studied periods. Throughout the 
study period, the proportion of patients with NSDs 
was highest, and the percentage of patients with NCs 
was consistently low.
Within the first period, the most consider-
able portion of patients with PCs was found in the 
Strength and Stroke recovery domains - 18.88% each, 
followed by Hand function - 17.48%, and Participa-
tion - 14.69%. For the same period, the lowest PCs 
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whole physical dimension- 6.29%. Only 2.8% of pa-
tients had PCs in the overall QoL. The NCs were 
most pronounced in the Emotion domain - 5.59%, 
followed by Hand function and Participation with 
2.10%, respectively.
During the second period, significantly small-
er differences in mean changes were reported in 
all SIS 3.0 domain. The proportion of participants 
with NSD during this period significantly dominat-
ed. The highest PCs were reported in Stroke recov-
ery - 13.29%, followed by Hand function - 8.39% and 
Emotion and Mobility respectively by 6.99%. A mi-
nor share of the participants was with NCs, as this 
was more pronounced for the domains Memory 
and thinking, Emotion, and Participation by 1.40%, 
respectively.
The third period includes aggregated data for 
MCIDs from discharge until the end of the third 
month after the stroke. As expected, due to the lon-
ger duration, the most significant changes are re-
ported here. PCs covered up to one-third of the stud-
ied population concerning the domains Stroke re-
covery - 34.97%, Strength - 33.57%, and Mobility - 
31.47%. The domain of Memory and thinking had 
the lowest level of PCs - 13.29%. A total of 18.18% of 
patients reported a significant improvement in their 
overall QoL after ischemic stroke. The proportion of 
patients with NCs was significantly lower than that 
of PCs. The most pronounced NCs were found in 
the domains Participation - 4.90%, Emotion - 4.20%, 
and Hand function - 3.50%.
Detailed information on the distribution of MC-
IDs in the different periods is presented in Table 3.
DISCUSSION
The present study examined the HR-QoL in 
adult ischemic stroke survivors and evaluated the 
MCIDs distribution. 
Our results emphasize the severe impairment 
in the Health-related Quality of life (HR-QoL) as-
sessed with the SIS 3.0. All subscales of this stroke-
specific tool showed a variable degree of affection 
in the different domains. The most affected fields 
at the end of the study period were Hand function 
(66.29±34.18), Mobility (68.80±30.16), Participation/
Role function (65.3±27.35), and the whole physical 























































































































































































































































































































































































































































































































































































































Table 3. Minimal clinically important difference (MCID) 
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in other HR-QoL studies (13,14). Patients with more 
severe alterations in the physical dimension were 
found to have a much worse total QoL in the third 
month. Perhaps these findings can be explained by 
the fact that physical disability is the primary con-
cern of most stroke patients because of its direct ef-
fect on their ADL and hence, HR-QoL. On the oth-
er hand, it has been proven that stroke causes a suffi-
cient decrease in HR-QoL, even in those who do not 
have severe physical symptoms and disability (12).
Tracking the changes in HR-QoL, we found 
that it remains significantly decreased till the third 
month post-stroke. The mean values dynamics were 
in a broader range during the first period, proving 
the faster recovery in the early period than the late 
periods (15). There was much quicker functional im-
provement in the first month due to the recovery of 
neurotransmission and neuromodulation in the pre-
served brain tissue near the ischemic zone (16). Af-
ter the first month, the recovery tended to slow down 
and reach a plateau between the third and the sixth 
month post-stroke (12). The domain with the most 
significant recovery rates was Emotion (p<0.001). 
It was followed by Mobility (p=0.004), Strength 
(p=0.007), the overall physical dimension (p=0.049), 
and the total QoL (0.019). These findings are con-
sistent with previous studies reporting the most in-
tensive dynamics in the emotional and physical do-
mains (17). A plausible explanation for these results 
could be the post-stroke depression and the effect of 
post-stroke rehabilitation.
MCIDs represent the proportion of the pa-
tients who had positive, negative, or no changes in 
their condition during follow-up according to the 
SIS 3.0 scale. Determining MCID is crucial for judg-
ing whether there is a real change in HR-QoL and 
its magnitude (18). There is no defined range of the 
change score in MCID. Nevertheless, previous stud-
ies determined MCID as 10% of the scales’ entire 
range for hemiparetic patients (19) and 10-15% for 
the general stroke population (4). We used a broader 
range of 15% difference in the total domain score as 
an MCID measure.
Our study proves that most patients have no 
significant difference in their HR-QoL and the indi-
vidual domains of SIS. Nevertheless, there is a preva-
lence of patients with PCs over those with NCs dur-
ing the first three months post-stroke.
During the first period, we found more patients 
with PCs in the physical domains – Strength, Hand 
function, Mobility, and Participation. These results 
are consistent with previous reports (20). The expla-
nation of these findings is the early initiation of phys-
ical rehabilitation and continuation of its implemen-
tation after discharge. We found pronounced chang-
es in the Emotion domain, as the most consider-
able portion of NCs were in this domain during this 
first period. While 12.59% of the patients were with 
PCs, there were 5.59% of them with NCs. The larg-
er share of NCs can be explained with post-stroke 
depression, a common finding with a prevalence of 
29% anytime after stroke (21). Only minor dynam-
ics were observed in the second period, as the chang-
es in the PC and NC groups were less than 10% of 
all the participants. At the end of the study period, 
we again found the most pronounced physical di-
mension changes. We noted that out of all patients 
with PCs, the smallest was the share of those with 
improvement in Memory and thinking, Communi-
cation, and ADL. These results highlight the persis-
tent impairment of cognitive function and memory 
dysfunction after stroke (22). Therefore, for patients 
who have suffered a stroke, it is essential to conduct 
not only physical rehabilitation but also speech reha-
bilitation and timely social and mental support.
Limitations:
We acknowledge the following limitations in 
our study. First, our cohort represents patients pre-
dominantly with minor and moderate stroke. Other 
aspects related to stroke outcomes like psychoemo-
tional disorders, family, and social support can also 
influence the HR-QoL and were not analyzed in the 
present study. We used a constant limit of 15% to de-
termine MCID, while this value may vary for indi-
vidual domains on the SIS 3.0 scale. Consequently, 
the results likely underestimate the full impact of 
stroke on the wellbeing of stroke survivors.
CONCLUSION 
Despite the trend to improve over time, the HR-
QoL after stroke remains severely impaired up to the 
third month post-stroke. The distribution of patients 
with MCIDs proved that the physical aspects of HR-
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QoL are the most affected, with an additional high 
level of engagement of the emotional sphere. 
Stroke survivors require a holistic approach 
during the recovery period after the acute accident. 
They need to conduct both physical and speech 
rehabilitation and to receive timely social and mental 
support.
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